Donate
info@cureduchenne.org(949) 872-2552
EventsContact
Cart
×

No products in the cart.

CureDuchenne
Moble Nav Icon
  • Cure
    • Research Overview
    • Research Terms
    • Exon Skipping
    • Clinical Trials
  • Care
    • COVID-19 Resources
    • Newly Diagnosed
    • Clinics
    • Steroid Use
    • Emergency Care
    • Resource Library
    • DME Guide
    • Medical ID Bracelets
    • Navigating School
    • Occupational Therapy
    • Physical Therapy
    • For Families
    • - Find a Physical Therapist
    • - Pool Activities
    • - Stretching
    • For Physical Therapists
    • - PT Certification
    • - Professional Courses
    • For Clinics
  • Community
    • CureDuchenne CARES
    • CureDuchenne FUTURES
    • CureDuchenne Champions
    • Family Stories
    • Events
    • Previous Webinars
    • Family Fundraisers
  • About Us
    • Mission
    • Vision
    • About Duchenne
    • Blog
    • Board of Directors
    • Sponsors
    • Reports and Financials
    • Events & Webinars
    • News Center
    • - Press Releases
    • - Research
  • CD Ventures
    • About CD Ventures
    • Our Impact
  • Get Involved
    • Donate
    • More Ways to Give
    • Fundraise
    • Shop
    • Fundraising Events
    • - Ladies Luncheon Austin
    • - CureDuchenne Golf Shootout | Orange County, CA
    • - Napa in Newport | Orange County, CA
  • Donate

CureDuchenne Hosts Accelerateed Access Webinar with the FDA

February 14, 2013 - Posted in Press Releases

Related Posts

  • Lidia_Gardner
    CureDuchenne Appoints Lidia Gardner, PhD, EMBA, as Vice President of Clinical and Medical Affairs to Advance Patient-Centered Care, Research, and Strategic Partnerships
    May 20, 2026
  • CureDuchenne Announces Partnership with Tevard Biosciences to Advance Suppressor tRNA Therapy for the Treatment of Duchenne Muscular Dystrophy
    May 20, 2026
  • RegenXBio announces positive topline results from pivotal Phase 3 microdystrophin gene therapy trial
    May 14, 2026
  • Global Nonprofit CureDuchenne to Host FUTURES National Conference for the Duchenne and Becker Muscular Dystrophy Community on May 21-24 in Orlando, FL
    April 30, 2026

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate

Search

Recent Posts

  • Italfarmaco reports positive data from the EPIDYS trial and its ongoing open-label extension of givinostat in Duchenne
    July 8, 2026
  • Satellos reports positive interim data from adults treated with SAT-3247
    July 8, 2026
  • FDA accepts Sarepta’s application to convert AMONDYS 45 and VYONDYS 53 from accelerated to full approval
    June 30, 2026
  • Update from Solid on microdystrophin gene therapy program
    June 26, 2026
  • FDA will hold Advisory Committee meeting on July 29th to review deramiocel for treatment of Duchenne
    June 26, 2026

Categories

  • Cure Duchenne Blog
  • Press Releases
  • In the News
  • Research Articles

Categories

  • All Categories
  • 2024 FUTURES
  • Clinical Care
  • Community
  • Equipment
  • Financial Assistance
  • Industry Presentations
  • Mental Health
  • Physical Therapy
  • Recursos en español
  • Research and Clinical Trials
  • School
  • About

    • Mission
    • About Duchenne MD
    • Blog
    • Store
    • News Center
  • Get Involved

    • Donate
    • Fundraising
    • Attend an Event
  • CureDuchenne

    • 100 Bayview Circle, Suite 5600
      Newport Beach, CA 92660
      (949) 872-2552
      info@cureduchenne.org

  • Get Connected

PRIVACY POLICY | TERMS OF USE | INDIRECT COST POLICY | TAX INFO

CureDuchenne is a 501c3 registered tax-exempt nonprofit organization. Federal Tax ID: #20-0299958 | ©2026 CureDuchenne. All rights reserved.

Please be advised that the contents within the CureDuchenne site include a compilation of articles, advisements, and references from the community. CureDuchenne does not provide medical advice nor is CureDuchenne a medical provider. The intent of this shared content is to serve as a point of reference for informational purposes. Please refer to your health care provider(s) for your individualized, specific care management needs. The CureDuchenne website may contain links to external websites that are not provided and/or maintained by or in any way affiliated with CureDuchenne. CureDuchenne recommends that you review the terms of service and privacy policies of these external websites before entering. Please note that CureDuchenne does not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you are agreeing to accept our use of cookies. For more information about cookies please visit our Privacy Policy page.